Within a cellular clinical viewpoint, Relafen 750 (Naproxen) exhibits distinct behaviors. It works primarily as a non-copyrightal medication , largely inhibiting cyclooxygenase-2 (COX-2), an enzyme participating in prostaglandin production . This specific inhibition generates reduced inflammation and ache, delivering therapeutic advantages for pati